Key result
Angiotensin receptor antagonists have demonstrated beneficial effects on hard clinical endpoints in patients with hypertension, heart failure, diabetic nephropathy, and post-myocardial infarction.
This review summarizes the historical and clinical evidence supporting the use of angiotensin receptor antagonists across various cardiovascular and renal diseases.
No takes yet. Share an insight, caveat, or question.
Reinforces ARB benefits across indications; confirms prior syntheses but leaves open needs for updated comparative trials.
Carlos M. Ferrario (2006) conducted a review in Cardiovascular diseases (hypertension, heart failure, diabetic nephropathy, post-myocardial infarction). Angiotensin receptor antagonists (AIIAs/ARBs) was evaluated. Angiotensin receptor antagonists have demonstrated beneficial effects on hard clinical endpoints in patients with hypertension, heart failure, diabetic nephropathy, and post-myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: